ProMem metrifonate acetylcholinesterase inhibitor regulatory update

Bayer submitted to the FDA an amended NDA for ProMem to treat mild to moderate Alzheimer’s disease. In an action letter regarding the original NDA submission, the FDA had expressed concerns over muscl...